Compound sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5.
Lijun LiuYinli ZhangShengyun LiuCong WangLei ZhangWenjuan GuanXin ZhangWei LiXiaoming ShuTian-Fang LiPublished in: Rheumatology (Oxford, England) (2023)
Prophylactic use of SMZ Co is an effective and safe way to improve the prognosis of anti-MDA5-DM patients by preventing the incidence of PJP.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- risk factors
- adipose tissue
- gene expression
- rheumatoid arthritis
- metabolic syndrome
- patient reported outcomes
- systemic lupus erythematosus
- cell proliferation
- signaling pathway
- insulin resistance
- wastewater treatment
- skeletal muscle
- copy number
- microbial community
- idiopathic pulmonary fibrosis